SF 1771 makes several modifications to the medical cannabis statutes.
Section 1 (152.25, subd. 1) modifies the time period in which medical cannabis manufacturers must register with the Commissioner of Health from every year to every three years.
Section 2 (152.27, subd. 6) requires the commissioner to approve or deny a patient's application for participation in the registry program within 30 days after receipt of the application and application fee. Permits the commissioner to take up to 60 days to approve or deny until January 1, 2016. Specifies that a patient's enrollment in the program is revoked upon the death of the patient.
Section 3 (152.37, subd. 2) clarifies that the annual certified financial audit that each medical cannabis manufacturer must submit to the commissioner for the calendar year beginning January 2015.
Section 4 changes the date in which the Commissioner of Health must report to the task force on medical cannabis therapeutic research the findings on the need for adding intractable pain to the list of qualifying medical conditions from July 1, 2016, to January 1, 2016.
|